Every day in the United States, close to 6,000 women enter the phase of menopause, a natural transition that typically begins around the age of 51. However, perimenopause, its precursor, can onset even earlier. This transformative period brings with it an array of challenges, including hot flashes, insomnia, anxiety, depression, memory lapses, and more, profoundly impacting women’s lives and careers.
Yet, despite the significant toll menopausal symptoms can take, very few healthcare practitioners are adequately trained to manage this transitional phase. Consequently, many women remain underdiagnosed and undertreated. Bridging this critical gap in women’s healthcare, Midi Health is on a mission to redefine midlife healthcare for women.
In a recent breakthrough development, Midi Health, a pioneering force in women's midlife healthcare, has secured $25 million in a Series A funding round led by Google Ventures (GV), renowned for its support of groundbreaking ventures like Nimbus Therapeutics. Notably, investors Frederique Dame and Cathy Friedman from GV have joined the ranks, alongside existing backers Felicis, Semper Virens, Icon, 25M, and Operator Collective. This latest funding infusion propels Midi Health's total funding to an impressive $40 million.
The funds will serve as a catalyst for Midi Health's ambitious expansion plans, enabling the company to extend its reach nationwide. Additionally, Midi Health aims to establish strategic partnerships with major US hospital systems and prominent employers. Having already positively impacted tens of thousands of patients with healthcare coverage accepted by major insurance carriers, the company's sights are set on achieving a presence in all 50 states by January 2024.
Frederique Dame, General Partner at GV, expressed her confidence in Midi Health's mission, stating, "Midi’s world-class executive and advisory team has decades of clinical and healthcare expertise and a vision for personalized, affordable, and accessible midlife care. GV is proud to back Midi as they modernize perimenopause and menopause care for women everywhere."
Joanna Strober, CEO & Founder of Midi Health, emphasized the company's dedication to addressing a critical healthcare gap and promoting equity in women's healthcare. Strober noted, "Midi provides an insurance-covered solution that focuses on women’s unique needs, closing a major gap in health access, quality, and equity."
Founded in 2021 by Joanna Strober, Midi Health stands as a virtual care clinic committed to making expert care accessible and affordable for women navigating the hormonal changes of midlife. The company offers specialized treatment for common perimenopausal and menopausal symptoms, coupled with preventative care to support long-term health.
Midi Health is further enhancing its team of clinicians, rigorously trained in women's health and engaged in ongoing education under the guidance of perimenopause and menopause experts. Patients receive personalized care plans tailored to their unique symptoms and health history, featuring solutions encompassing hormonal and non-hormonal medications, supplements, lifestyle coaching, and essential preventative health guidance. All services are insurance-covered and conveniently accessible through telehealth appointments and 24/7 messaging support, with a remarkable patient satisfaction score of 95%.
